OTCMPHBI
Market cap1mUSD
Dec 26, Last price
0.00USD
1D
3.03%
1Q
-63.04%
IPO
-99.93%
Name
Pharmagreen Biotech Inc
Chart & Performance
Profile
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
Income | |||||||
Revenues | 3 | ||||||
Cost of revenue | 470 | 1,070 | |||||
Unusual Expense (Income) | |||||||
NOPBT | (467) | (1,070) | |||||
NOPBT Margin | |||||||
Operating Taxes | (242) | ||||||
Tax Rate | |||||||
NOPAT | (467) | (828) | |||||
Net income | (569) -10.29% | (634) -88.55% | |||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 187 | ||||||
BB yield | |||||||
Debt | |||||||
Debt current | 282 | 219 | |||||
Long-term debt | 91 | 119 | |||||
Deferred revenue | |||||||
Other long-term liabilities | (119) | ||||||
Net debt | 283 | 331 | |||||
Cash flow | |||||||
Cash from operating activities | (74) | (427) | |||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | 83 | 314 | |||||
FCF | (53) | (767) | |||||
Balance | |||||||
Cash | 1 | 8 | |||||
Long term investments | 89 | ||||||
Excess cash | 90 | 8 | |||||
Stockholders' equity | (12,541) | (12,086) | |||||
Invested Capital | 10,733 | 10,601 | |||||
ROIC | |||||||
ROCE | 25.80% | 72.08% | |||||
EV | |||||||
Common stock shares outstanding | 466,532 | 403,733 | |||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | (467) | (1,070) | |||||
EV/EBITDA | |||||||
Interest | 121 | 47 | |||||
Interest/NOPBT |